Concord Biotech Limited — Mycophenolate Exporter Profile
Indian Pharmaceutical Exporter · #6 for Mycophenolate · $6.0M export value · DGFT Verified
Concord Biotech Limited is the #6 Indian exporter of Mycophenolate with $6.0M in export value and 119 verified shipments. Concord Biotech Limited holds a 1.8% market share in Mycophenolate exports across 8 countries. The company exports 3 pharmaceutical products worth $6.9M across 1 therapeutic categories.
Concord Biotech Limited — Mycophenolate Export Profile: Buyers & Destinations
Where Does Concord Biotech Limited Export Mycophenolate?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.6M | 95 | 89.8% |
| MEXICO | $300.0K | 6 | 7.6% |
| INDONESIA | $83.5K | 6 | 2.1% |
| BANGLADESH | $8.4K | 1 | 0.2% |
| TURKEY | $8.4K | 2 | 0.2% |
| UNITED ARAB EMIRATES | $2.3K | 1 | 0.1% |
| IRAQ | $2.2K | 1 | 0.1% |
| AZARBAIJAN | $0 | 10 | 0.0% |
Concord Biotech Limited exports Mycophenolate to 8 countries. The largest destination is UNITED STATES accounting for 89.8% of Concord Biotech Limited's Mycophenolate shipments, followed by MEXICO (7.6%) and INDONESIA (2.1%). These destinations reflect Concord Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mycophenolate from Concord Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | UNITED STATES | $3.0M | 83 |
| TO THE ORDER, | UNITED STATES | $221.6K | 5 |
| CARITAS PHARMA S A DE C V | MEXICO | $200.0K | 4 |
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $164.9K | 4 |
| CARITAS PHARMA S.A. DE C.V | MEXICO | $100.0K | 2 |
| WOODFIELD DAYTON WOODFIELD DISTRIBUTION LCC | UNITED STATES | $75.5K | 2 |
| PT. PARIT PADANG GLOBAL | INDONESIA | $71.3K | 5 |
| PT.PARIT PADANG GLOBAL | INDONESIA | $12.2K | 1 |
| TO THE ORDER OF | BANGLADESH | $8.4K | 1 |
| PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR | TURKEY | $5.5K | 1 |
Concord Biotech Limited supplies Mycophenolate to 13 buyers globally. The largest buyer is TO THE ORDER (UNITED STATES), followed by TO THE ORDER, (UNITED STATES) and CARITAS PHARMA S A DE C V (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mycophenolate Export Value and How Much Does Concord Biotech Limited Contribute?
India exported $86.9M worth of Mycophenolate through 2,529 shipments from 167 suppliers to 100 countries, serving 512 buyers globally. Concord Biotech Limited contributes $6.0M to this total, accounting for 1.8% of India's Mycophenolate exports. Concord Biotech Limited ships Mycophenolate to 8 countries through 13 buyers.
What Is the Average Shipment Value for Concord Biotech Limited's Mycophenolate Exports?
Concord Biotech Limited's average Mycophenolate shipment value is $50.0K per consignment, based on 119 shipments totaling $6.0M. The largest destination is UNITED STATES (89.8% of Concord Biotech Limited's Mycophenolate exports).
How Does Concord Biotech Limited Compare to Other Indian Mycophenolate Exporters?
Concord Biotech Limited ranks #6 among 167 Indian Mycophenolate exporters with a 1.8% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($22.7M), ALKEM LABORATORIES LIMITED ($17.8M), EMCURE PHARMACEUTICALS LIMITED ($14.0M). Concord Biotech Limited processed 119 shipments to 8 destination countries.
What Mycophenolate Formulations Does Concord Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MYCOPHENOLATE MOFETIL TABLETS USP 500 MG(100'S) NDC NO. 72888-185-01 | $191.1K | 4 |
| PHARMACEUTICALS PRODUCTS:MYCOPHENOLATE MOFETIL TABLETS USP 500 MG (100'S) NDC NO. 72888-185-01 | $151.1K | 4 |
| PHARMACEUTICALS PRODUCTS MMF CORD MYCOPHENOLATE MOFETIL TABLET 500 MG MICOFENOLATO DE MOFETILO TABLETA 500 MG | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL CAP USP 250MG(100S) BNO.MYUS23013A,14A,MYUS24001A-4A MFGDT:DEC23/JAN24 EXPDT:NOV/DEC26NOS | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500 MG(100'S) BNO.MMUS23016A24001A2A3A4A5A6A MFGDT:DEC23JAN24FEB24 EXPDT:NOV2TBS | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL CAPSULES USP 250 MG (100'S) NDC NO. 72888-192-01 | $150.0K | 3 |
| Pharmaceuticals Products :MycophenolateMofetil Capsules USP 250 mg (100's) NDCNO. 72888-192-01(38112X100'S) | $149.0K | 3 |
| PHARMACEUTICALS PRODUCTS:MYCOPHENOLATE MOFETIL CAPSULES USP 250 MG (100'S) NDC NO.72888-192-01, | $140.5K | 3 |
| Pharmaceuticals Products :MycophenolateMofetil Tablets USP 500 mg (100's) NDC NO. 72888-185-01(15408X100'S) | $130.9K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500 MG(100'S) BNO.MMUS23017A-20A MFGDT: DEC23EXPDT: NOV25NOS | $125.3K | 3 |
Concord Biotech Limited exports 71 distinct Mycophenolate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MYCOPHENOLATE MOFETIL TABLETS USP 500 MG(100'S) NDC NO. 7288 with 4 shipments worth $191.1K.
Regulatory Requirements: Exporting Mycophenolate to Key Markets
What Concord Biotech Limited must comply with to export Mycophenolate to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Concord Biotech Limited Compare to Nearest Mycophenolate Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | SANDOZ PRIVATE LIMITED | $10.2M | 204 | 8 | $50.0K |
| 2 | STRIDES PHARMA SCIENCE LIMITED | $9.7M | 193 | 3 | $50.0K |
| 6 | CONCORD BIOTECH LIMITED ★ | $6.0M | 119 | 8 | $50.0K |
| 8 | MYLAN LABORATORIES LIMITED | $1.8M | 36 | 4 | $50.0K |
| 7 | PANACEA BIOTEC PHARMA LIMITED | $1.8M | 35 | 9 | $50.0K |
Concord Biotech Limited ranks #6 among 167 Indian Mycophenolate exporters. Average shipment value of $50.0K compared to the market average of $520.1K. The closest competitors by value are SANDOZ PRIVATE LIMITED and STRIDES PHARMA SCIENCE LIMITED.
Which Indian Ports Ship Mycophenolate Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 464 | 18.3% |
| NHAVA SHEVA SEA (INNSA1) | 308 | 12.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 229 | 9.1% |
| JNPT/ NHAVA SHEVA SEA | 135 | 5.3% |
| DELHI AIR | 115 | 4.5% |
| AHEMDABAD AIR ACC (INAMD4) | 108 | 4.3% |
| MUNDRA SEA | 97 | 3.8% |
| BANGALORE ICD | 97 | 3.8% |
What Other Immunosuppressants Products Does Concord Biotech Limited Export?
Concord Biotech Limited also exports these immunosuppressants products. Each links to the detailed product page.
About Concord Biotech Limited
Concord Biotech Limited exports 3 products worth $6.9M. Beyond Mycophenolate, top products include Cyclosporine, Sirolimus. View the complete Concord Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mycophenolate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mycophenolate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Concord Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 122 individual customs records matching Concord Biotech Limited exporting Mycophenolate, covering 71 formulations to 8 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 512+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mycophenolate Export Data from Concord Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Concord Biotech Limited's Mycophenolate exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Concord Biotech Limited
Full Company Profile →
3 products · $6.9M total trade · 1 categories
Mycophenolate Stats
Company Overview
Top Products by Concord Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Concord Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mycophenolate. For current shipment-level data, contact TransData Nexus.